Literature DB >> 25361946

ERK and β-arrestin interaction: a converging point of signaling pathways for multiple types of cell surface receptors.

Haifeng Eishingdrelo1, Wei Sun2, Hua Li3, Li Wang3, Alex Eishingdrelo3, Sheng Dai2, John C McKew2, Wei Zheng2.   

Abstract

β-Arrestin, a signal adaptor protein, mediates intracellular signal transductions through protein-protein interactions by bringing two or more proteins in proximity. Extracellular signal-regulated kinase (ERK), a protein kinase in the family of mitogen-activated protein kinases (MAPKs), is involved in various receptor signal pathways. Interaction of ERK with β-arrestin or formation of ERK/β-arrestin signal complex occurs in response to activation of a variety of cell surface receptors. The ERK/β-arrestin signal complex may be a common transducer to converge a variety of extracellular stimuli to similar downstream intracellular signaling pathways. By using a cell-based protein-protein interaction LinkLight assay technology, we demonstrate a direct interaction between ERK and β-arrestin in response to extracellular stimuli, which can be sensitively and quantitatively monitored. Activations of G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and cytokine receptors promote formation of the ERK/β-arrestin signal complex. Our data indicate that the ERK/β-arrestin signal complex is a common transducer that participates in a variety of receptor signaling pathways. Furthermore, we demonstrate that receptor antagonists or kinase inhibitors can block the agonist-induced ERK and β-arrestin interaction. Thus, the ERK/β-arrestin interaction assay is useful for screening of new receptor modulators.
© 2014 Society for Laboratory Automation and Screening.

Entities:  

Keywords:  ERK; extracellular signal-regulated kinases; protein-protein interactions; β-arrestin

Mesh:

Substances:

Year:  2014        PMID: 25361946      PMCID: PMC4975872          DOI: 10.1177/1087057114557233

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  30 in total

Review 1.  'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors.

Authors:  L M Luttrell
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

2.  Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.

Authors:  Guido Boerrigter; Michael W Lark; Erin J Whalen; David G Soergel; Jonathan D Violin; John C Burnett
Journal:  Circ Heart Fail       Date:  2011-08-11       Impact factor: 8.790

Review 3.  Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins.

Authors:  Christopher J Hupfeld; Jerrold M Olefsky
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 4.  GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.

Authors:  Nicolas Delcourt; Joël Bockaert; Philippe Marin
Journal:  Trends Pharmacol Sci       Date:  2007-11-14       Impact factor: 14.819

Review 5.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

Review 6.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

7.  Comparing label-free biosensors for pharmacological screening with cell-based functional assays.

Authors:  Matthew F Peters; François Vaillancourt; Madeleine Heroux; Manon Valiquette; Clay W Scott
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

8.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 9.  β-Arrestin-kinase scaffolds: turn them on or turn them off?

Authors:  Alice Lin; Kathryn A DeFea
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-01-14

10.  Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.

Authors:  R R Matsumoto; W D Bowen; M A Tom; V N Vo; D D Truong; B R De Costa
Journal:  Eur J Pharmacol       Date:  1995-07-14       Impact factor: 4.432

View more
  11 in total

1.  Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor.

Authors:  Ali I Kaya; Nicole A Perry; Vsevolod V Gurevich; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-05       Impact factor: 11.205

2.  The Two Non-Visual Arrestins Engage ERK2 Differently.

Authors:  Nicole A Perry-Hauser; Jesse B Hopkins; Ya Zhuo; Chen Zheng; Ivette Perez; Kathryn M Schultz; Sergey A Vishnivetskiy; Ali I Kaya; Pankaj Sharma; Kevin N Dalby; Ka Young Chung; Candice S Klug; Vsevolod V Gurevich; T M Iverson
Journal:  J Mol Biol       Date:  2022-01-22       Impact factor: 5.469

3.  Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.

Authors:  Nicole A Perry; Tamer S Kaoud; Oscar O Ortega; Ali I Kaya; David J Marcus; John M Pleinis; Sandra Berndt; Qiuyan Chen; Xuanzhi Zhan; Kevin N Dalby; Carlos F Lopez; T M Iverson; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

4.  Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.

Authors:  Assunta Venuti; Claudia Pastori; Rosamaria Pennisi; Agostino Riva; Maria Teresa Sciortino; Lucia Lopalco
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

5.  The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.

Authors:  Assunta Venuti; Claudia Pastori; Gabriel Siracusano; Rosamaria Pennisi; Agostino Riva; Massimo Tommasino; Maria Teresa Sciortino; Lucia Lopalco
Journal:  Viruses       Date:  2017-12-28       Impact factor: 5.048

6.  G-protein-coupled receptors mediate 14-3-3 signal transduction.

Authors:  Hua Li; Alex Eishingdrelo; Sathapana Kongsamut; Haifeng Eishingdrelo
Journal:  Signal Transduct Target Ther       Date:  2016-09-30

7.  Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms.

Authors:  Haifeng Eishingdrelo; Xiaofa Qin; Luwa Yuan; Sathapana Kongsamut; Lei Yu
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-08-07

Review 8.  Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control.

Authors:  Yue Deng; Guorui Deng; Justin L Grobe; Huxing Cui
Journal:  Front Physiol       Date:  2021-06-28       Impact factor: 4.566

9.  14-3-3 signal adaptor and scaffold proteins mediate GPCR trafficking.

Authors:  Luwa Yuan; Shahar Barbash; Sathapana Kongsamut; Alex Eishingdrelo; Thomas P Sakmar; Haifeng Eishingdrelo
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

10.  Azelaic Acid Induces Mitochondrial Biogenesis in Skeletal Muscle by Activation of Olfactory Receptor 544.

Authors:  Trung Thanh Thach; Chunyan Wu; Kwang Yeon Hwang; Sung-Joon Lee
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.